IVF PulseFree Second Opinion

Oocyte immaturity; MII (metaphase II) rate; oocyte maturation arrest

Eggs were collected but too few were mature: what that means

The short answer

Only an egg that has reached metaphase II can be injected in ICSI 1. After standard stimulation, about 15-20% of the eggs collected are still immature 2. The ESHRE-ALPHA Vienna consensus expects 75-90% of collected eggs to be mature at ICSI, but that is a laboratory average across many patients, not a pass mark for your cycle 1.

The collection went ahead and you were given a number of eggs. Then the lab called with a second, smaller number: how many of those eggs were mature, and so how many could actually be injected. The gap between the two is not a clerical error and it is not something you did. It is a distinct stage of the cycle, sitting between collection and fertilisation, and it has its own explanations.

This page is about that stage. What maturity means on an embryology report, what share of eggs is normally mature at lab level, why the share can fall in one cycle, and what the ESHRE 2025 stimulation guideline, ESHRE's 2023 add-ons recommendations and the UK regulator say can be changed next time 1,2,4,5,6.

How common is this?

75-90%

Expected share of collected eggs that are mature (MII) at ICSI, measured 40 ± 1 hours after the trigger; ESHRE-ALPHA Vienna consensus reference indicator, in a reference group of women under 40 using their own fresh eggs1

about 15-20%

Share of eggs that fail to extrude the first polar body and reach MII after standard ovarian stimulation, staying at MI or GV (ESHRE/ALPHA Istanbul consensus update, 2025)2

74%

Minimum expected (competence) value for the proportion of MII eggs at ICSI when it is used as a clinical performance indicator, ESHRE Maribor consensus reference population3

2 or fewer from 6

Mature eggs from six collected, in at least two cycles: the threshold a 2026 review in Human Reproduction proposes for calling it oocyte maturation arrest and investigating it genetically12

Reading your report

MII (metaphase II)
A mature egg. It has finished the first division of meiosis and pushed out the first polar body. Only MII eggs can be injected in ICSI 1,2.
MI (metaphase I)
An immature egg, part-way through the first division, with no polar body yet. Immature eggs are usually not inseminated and are discarded 2.
GV (germinal vesicle)
The least mature stage: the egg's nucleus is still intact and visible as a round vesicle. Also called prophase I 2.
COC (cumulus-oocyte complex)
What is actually aspirated from a follicle: the egg inside its cloud of cumulus cells. The maturity rate is counted against COCs retrieved, not against follicles 1.
Denudation
Stripping the cumulus cells off the egg. Maturity cannot be assessed until this is done, which is why a maturity count normally appears only when ICSI is used 1.
Maturity rate (%MII)
Mature eggs at ICSI divided by all cumulus-oocyte complexes collected 1,3.
Telophase I
A stage in which a polar body is already visible but the egg has not finished dividing. Under polarised light some eggs with a polar body turn out to be at this stage, so a polar body alone does not prove maturity 2.
Nuclear vs cytoplasmic maturity
MII describes the chromosomes only. The Vienna consensus notes that nuclear maturity does not necessarily mean the rest of the egg is ready 1.
Rescue IVM
Culturing the immature eggs from a stimulated cycle in the hope they mature and can be injected 2,5.

Likely causes, most common first

CauseHow you'd knowTest that tells you
The gap between the trigger and the collectionCollection is normally 34-38 hours after the trigger, most often 36 1. A meta-analysis of 5 randomised trials in 895 women found a higher share of mature eggs when the gap was longer than 36 hours 9; an updated 2023 review of 12 studies found similar maturation rates between short and long gaps, with higher clinical pregnancy in the longer group 10Ask for the exact trigger time and the exact collection time from your cycle sheet
The trigger did not act as strongly as expectedIn 508 antagonist cycles triggered with a GnRH agonist, the LH and progesterone measured after the trigger, and the size of the LH rise, each predicted how many total and mature eggs were collected; the authors found no cut-off value that predicted yield 11Post-trigger LH and progesterone, if your clinic measures them after an agonist trigger 11
Follicles growing out of step, and small follicles being aspiratedThe Vienna consensus says instability in the maturity rate can reflect a change in stimulation producing more immature or more post-mature eggs 1. ESHRE's ultrasound working group notes small follicles under 10 mm can be left un-punctured to avoid collecting immature eggs, unless there is a high risk of OHSS 15Ask for the follicle sizes on the day of trigger and how many follicles were aspirated
The trigger drug itself, if it did not suit the cycleIn predicted healthy responders this is unlikely to be the explanation: a network meta-analysis of 12 randomised trials in 1,931 women found no difference in the number of mature eggs between hCG, GnRH agonist, dual and double triggers 7Ask which trigger was used and why it was chosen 4
An oocyte maturation abnormality in the eggs themselvesThe pattern is repetition: a very low mature share in more than one cycle, despite eggs being collected. A 2026 review in Human Reproduction proposes calling it maturation arrest when two or fewer mature eggs come from six collected, in at least two cycles 12Review of every previous cycle's maturity counts; genetic assessment is a specialist discussion, not a routine test 12,14

What did not cause this

  • "My weight is why the eggs were immature"

    In 5,190 stimulation cycles at one Barcelona centre, body mass index was not associated with the oocyte maturation rate (odds ratio 1.00, 95% CI 0.99-1.01), nor with the number of mature eggs, and this held for hCG, agonist and dual triggers alike 17.

  • "I should have asked for a different trigger injection"

    In predicted healthy responders, a network meta-analysis of 12 randomised trials and 1,931 women found no significant difference in the number of mature eggs between hCG, GnRH agonist, dual and double triggers 7. ESHRE's 2025 guideline also does not recommend adding a GnRH agonist to hCG as a dual trigger for predicted normal responders or for low responders 4.

  • "The embryologist must have mishandled my eggs"

    The Vienna consensus classifies the mature-egg share as a reference indicator rather than a laboratory performance indicator, precisely because its value is not influenced by laboratory practice; it reflects what arrives in the lab 1. When it falls outside the expected range, the consensus asks for a review of stimulation, triggering or follicle aspiration 1.

What do MII, MI and GV mean on my report?

They are three stages of one process. A germinal vesicle (GV) egg still has its nucleus intact. A metaphase I (MI) egg has begun dividing but has not finished. A metaphase II (MII) egg has completed the first division and pushed out the first polar body, and only an MII egg can be injected with a sperm in ICSI 1,2. Immature eggs are usually not inseminated and are discarded 2.

Maturity can only be read once the cumulus cells around the egg are stripped away, which happens in preparation for ICSI 1. That is why a cycle done with conventional IVF often has no maturity count at all: the eggs are never denuded, so nobody looked 1.

A polar body is the usual sign of maturity, but it is not proof. Studies using polarised light have shown that some eggs with a visible polar body are still at telophase I, still finishing the division, and only the meiosis II spindle confirms maturity 2. And maturity of the chromosomes is not maturity of the whole egg: the Vienna consensus notes that nuclear maturity does not necessarily indicate cytoplasmic maturity 1.

What maturity rate is a lab expected to reach?

The ESHRE-ALPHA Vienna consensus sets an expected range of 75-90% for the proportion of MII eggs at ICSI, measured 40 ± 1 hours after the trigger and counted against all cumulus-oocyte complexes retrieved 1. The ESHRE Maribor consensus later adopted the same measure as a clinical performance indicator, with a minimum expected value of 74% and the same 75-90% benchmark 3.

Read the denominator before you read the number. It is mature eggs divided by every egg collected, including any that came from the smallest follicles 1. The figures also describe a defined reference group: women under 40, using their own fresh eggs, with ejaculated sperm and no genetic testing 1.

Most importantly, it is an average over many cycles. With six eggs collected, one egg more or less moves your rate by about 17 percentage points, which is why a single cycle below the range is not evidence of anything on its own. The Vienna consensus treats the indicator as so stable that labs may report it by exception, and says values outside the expected range should prompt a review of stimulation, triggering or follicle aspiration practice 1.

Why were so few of my eggs mature?

The trigger and its timing come first, because the mature-egg share is treated as a proxy for how well stimulation and triggering worked, not for how well the lab worked 1,3. Collection is normally 34-38 hours after the trigger, most often 36 1. A 2011 meta-analysis of five randomised trials in 895 women found a higher share of mature eggs when that gap was longer than 36 hours, with no difference in fertilisation, implantation or pregnancy 9. An updated 2023 review of 12 studies found the maturation rates similar between shorter and longer gaps, with a higher clinical pregnancy rate in the longer group and no difference in live birth 10. The two reviews do not agree, which is itself the honest answer.

Whether the trigger took effect is a separate question from when it was given. In 508 antagonist cycles triggered with a GnRH agonist, the LH and progesterone levels after the trigger, and the size of the LH rise, each correlated with the number of total and mature eggs collected, although no single cut-off predicted the yield 11.

Then there is the cohort itself. Follicles do not grow in step, and the eggs inside smaller follicles are less likely to be mature. ESHRE's ultrasound working group notes that follicles under 10 mm can be left un-punctured to avoid collecting immature eggs, unless there is a high risk of OHSS 15. If the small ones were aspirated, they still count in the denominator. ESHRE's 2025 guideline says the link between follicle size at trigger and outcome has not been sufficiently studied, and leaves the choice to the clinician case by case, noting that final maturation is most often triggered when several leading follicles are 16-22 mm 4.

Finally, the eggs themselves. A minority of women have eggs that repeatedly fail to mature whatever is done to the stimulation, which is covered in the next section.

Could this be a problem with the eggs themselves?

Sometimes, and it is uncommon. In 2016, exome sequencing of a four-generation family with infertility due to oocyte meiosis I arrest identified mutations in TUBB8, a gene expressed almost only in oocytes and the early embryo; seven mutations were found in 7 of 24 affected families studied 13. Since then the list has grown, and a 2026 review in Human Reproduction identified 39 genes associated with oocyte, zygote and embryo maturation arrest across 132 published papers and 521 patients 12.

Two cautions matter more than the gene names. First, most gene-disease links in female reproductive failure are not yet firmly established: a 2022 systematic review classified 183 gene-disease pairs and rated only 24 as definitive and 36 as strong, with 81 limited and 23 with no evidence 14. Second, one cycle cannot make this diagnosis. The 2026 review's whole point is that you need enough eggs to tell a real defect from ordinary variation, and it proposes a threshold of two or fewer mature eggs from six collected, one or no zygote from six mature eggs, or no blastocysts from six normally fertilised eggs, in at least two treatment cycles 12.

That review was built from published cases of women already selected for poor IVF outcomes and known gene variants, so it says nothing about how often testing finds an answer in an unselected patient 12. It is a reason to ask the question after a repeated pattern, not after one cycle.

Can the immature eggs still be used?

Sometimes, by culturing them and injecting any that mature. This is rescue in vitro maturation, and it is not the same as the planned IVM described below. Timing appears to matter: the 2025 Istanbul consensus update reports that MI eggs which mature within 2-6 hours of denudation may be injected and can add to the number of embryos, while MI and GV eggs cultured overnight and maturing after 24 hours had poorer fertilisation and blastocyst formation, probably because they are more often chromosomally abnormal 2.

The evidence behind it is thin and observational. The Istanbul consensus update grades the association between immature MI eggs and lower fertilisation as low-quality from six observational studies, and the live births reported from rescue IVM as very low-quality from four observational studies 2. In the largest series ESHRE summarises, 440 poor responders with fewer than five mature eggs were split by whether their immature eggs were also cultured and injected; clinical pregnancy was 16.7% without and 16.5% with, but more embryos were available to transfer, and in 17 cycles the only embryos available came from rescue-matured eggs, producing two pregnancies 5.

ESHRE's 2023 add-ons group does not recommend clinical IVM or rescue IVM for routine clinical use, citing a lack of established effectiveness, procedural reliability and long-term safety data, and calls the safety of rescue IVM questionable because these eggs commonly have meiotic defects 5. The Istanbul consensus update says immature eggs could be considered where the prognosis is poor or there is no alternative, and that follow-up of babies born from rescue IVM demands attention 2. Rescue IVM is not on the HFEA's rated list of treatment add-ons 6.

Is IVM for PCOS the same thing?

No. Planned IVM is a different treatment: eggs are collected from small follicles after little or no stimulation and matured in the lab on purpose. The 2023 International Evidence-based Guideline for PCOS says IVM with ICSI could be considered in women with PCOS as an alternative to a stimulated cycle, with the embryo frozen and replaced later, acknowledging that there is no risk of OHSS but a lower cumulative live birth rate 16.

The same guideline says IVM should only be done in services with sufficient expertise, could be offered where the risk of severe OHSS is unacceptably high, and notes that IVM with ICSI is less effective than standard IVF or ICSI for clinical pregnancy and live birth per patient 16. ESHRE's add-ons group makes the same distinction: when IVM is used for PCOS, high responders or fertility preservation it is not considered an add-on at all 5.

So if a clinic offers you IVM, ask which one it means: a planned IVM cycle instead of stimulation, or rescue of the immature eggs from a stimulated cycle. They have different evidence behind them 5,16.

What does ESHRE's 2025 guideline say about changing the trigger?

Less than most clinics imply. ESHRE's 2025 update contains 121 recommendations and none of its evidence-based recommendations rests on high-quality evidence 4. On triggering, it treats recombinant and urinary hCG as equally recommended, does not recommend recombinant LH for triggering, and does not recommend a GnRH agonist trigger in the general IVF population having a fresh transfer 4. A GnRH agonist trigger is recommended when there is a risk of OHSS, combined with freezing all embryos 4.

On dual trigger, ESHRE says adding a GnRH agonist to hCG is probably not recommended for predicted normal responders and probably not recommended for low responders, both conditional recommendations 4. That matches the network meta-analysis of 12 randomised trials in 1,931 predicted healthy responders, which found no difference between trigger protocols in the number of mature eggs collected 7.

There is one exception worth naming, and it is small. A randomised trial enrolled 73 normal responders under 40 whose previous cycle had an immature-egg rate above 50%, and compared an hCG trigger with a dual trigger. The mature-egg share was 55.5% with hCG and 84.0% with the dual trigger, with a cumulative live birth rate of 36.0% against 66.7% 8. That is a single centre, 73 women, and a group selected for the exact problem this page is about; it is a reason to ask the question, not an answer.

It depends on…

Is this the first cycle in which the mature-egg share was low?

Yes, the first

One cycle below the 75-90% range is not a diagnosis, particularly with few eggs 1. The Vienna consensus asks for a review of stimulation, triggering and aspiration, not a new label 1.

No, it has happened before

Put the cycles side by side. A 2026 review in Human Reproduction proposes calling it maturation arrest at two or fewer mature eggs from six collected, in at least two cycles, and that is the point at which genetic assessment becomes a reasonable question 12.

Was the trigger an hCG injection, a GnRH agonist, or both?

hCG alone

ESHRE 2025 treats recombinant and urinary hCG as equally recommended 4. If the previous immature rate was above 50%, one randomised trial in 73 women found a dual trigger gave a higher mature-egg share 8.

A GnRH agonist

Ask whether LH and progesterone were measured after the trigger: in 508 agonist-trigger cycles both correlated with the number of mature eggs collected 11.

Both, as a dual trigger

Changing the trigger again is unlikely to be the lever. ESHRE 2025's dual-trigger recommendations are already against routine use, so the conversation moves to timing, follicle sizes and the eggs themselves 4,12.

The three maturity stages as they appear on an embryology report, and what the 2025 ESHRE/ALPHA Istanbul consensus update says about each

StageWhat it meansCan it be injected?What the evidence says
GV (germinal vesicle)Least mature; the egg's nucleus is still intact 2No, not as it is 2No clear association with fertilisation rate, very low-quality evidence from 2 observational studies 2
MI (metaphase I)Dividing, but no polar body yet 2No, not as it is 2Associated with a lower fertilisation rate, low-quality evidence from 6 observational studies 2
MII (metaphase II)Mature; first polar body extruded 1,2Yes; only MII eggs are injected in ICSI 1Expected in 75-90% of collected eggs at lab level 1
MI or GV after rescue IVMAn immature egg cultured until it matures 2,5Yes, if it reaches MII in culture 2Few live births reported, very low-quality evidence from 4 observational studies; not recommended for routine use 2,5

What's worth checking

  • Get the numbers in order: follicles on the day of trigger, eggs collected, eggs mature (MII), eggs injected, eggs fertilised.
  • Work out your own maturity rate: mature eggs divided by all eggs collected 1.
  • Write down the exact time of the trigger injection and the exact time of the collection.
  • Ask which trigger drug was used, and whether it was hCG, a GnRH agonist or both 4.
  • Ask for the follicle sizes on trigger day, and whether follicles under 10 mm were aspirated 15.
  • Ask whether any post-trigger blood test was done, if an agonist trigger was used 11.
  • If this has happened before, list the maturity counts from every cycle side by side 12.
  • Ask what happened to the immature eggs, and whether any were cultured 2,5.

What could change next cycle

8 options, by strength of evidence

  • Mixed, or some groups only 3
  • Not enough studies yet 3
  • Evidence says it doesn't help 2

Ratings follow the evidence reviews cited beside each option, not our opinion.

  • Reviewing the trigger-to-collection intervalMixed, or some groups only

    Vienna consensus: the usual window is 34-38 hours 1. The two meta-analyses disagree on whether a longer gap raises the mature-egg share 9,10.

  • Changing the trigger drug in an otherwise normal cycleEvidence says it doesn't help

    ESHRE 2025: a GnRH agonist trigger is not recommended in the general population having a fresh transfer 4; a network meta-analysis of 12 RCTs found no difference in mature-egg numbers 7.

  • Dual trigger for predicted normal or low responders generallyEvidence says it doesn't help

    ESHRE 2025: adding a GnRH agonist to hCG is probably not recommended for predicted normal responders, and probably not for low responders 4.

  • Dual trigger specifically after a cycle with a high immature-egg rateMixed, or some groups only

    One randomised trial in 73 selected women found a higher mature-egg share with a dual trigger 8; ESHRE's recommendation against dual trigger covers unselected responders, not this group 4.

  • Leaving the smallest follicles un-puncturedNot enough studies yet

    ESHRE ultrasound working group: follicles under 10 mm can be left un-punctured to avoid collecting immature eggs, unless OHSS risk is high 15; no outcome trial of the choice itself.

  • Rescue IVM of the immature eggsNot enough studies yet

    ESHRE add-ons 2023: not recommended for routine clinical use, with effectiveness and long-term safety not established 5; Istanbul 2025 rates the live-birth evidence very low 2.

  • Planned IVM instead of a stimulated cycle, with PCOS or high OHSS riskMixed, or some groups only

    2023 International PCOS Guideline: could be considered as an alternative, with no OHSS risk but a lower cumulative live birth rate, and only where expertise exists 16.

  • Genetic assessment after a repeated patternNot enough studies yet

    A 2026 review in Human Reproduction proposes thresholds over at least two cycles before investigating genetically 12; most gene-disease links in this area are not yet firmly established 14.

Questions to ask your doctor

  1. What was my mature-egg share, counted as mature eggs over all eggs collected?
  2. What were the follicle sizes on trigger day, and were any follicles under 10 mm aspirated?
  3. How many hours were there between my trigger injection and the collection, and would you change that?
  4. Would you change the trigger drug or add a second one, and what would you expect that to change?
  5. What happened to my immature eggs, and does this clinic offer rescue IVM?
  6. If this happens again, at what point would you suggest looking for a cause in the eggs themselves?

Questions people ask

What does GV mean on my embryology report?

GV stands for germinal vesicle, the least mature stage of an egg: its nucleus is still intact and visible 2. A GV egg cannot be injected as it is, and immature eggs are usually not inseminated 2. MI, or metaphase I, is the next stage up, still without a polar body, and MII is mature 2.

Why does my report say 10 eggs but only 5 were injected?

Because only the mature ones can be injected. In ICSI the cumulus cells are stripped off each egg first, and only eggs that have reached metaphase II are suitable for injection 1,2. The other five would have been at MI or GV. That makes your mature-egg share 50%, below the 75-90% the Vienna consensus expects at lab level, though that range describes an average across many patients 1.

Can an egg have a polar body and still be immature?

Yes. Work using polarised light microscopy has shown that some eggs with a first polar body in the perivitelline space are still at early telophase I, with the polar body not yet fully separated 2. The Istanbul consensus update says maturity can only be confirmed with certainty by seeing the meiosis II spindle in the cytoplasm, and that more evidence is needed on whether this assessment predicts how the embryo develops 2.

All my eggs were mature. Is that better?

It is not automatically a good sign on its own. The Vienna consensus gives an expected range of 75-90% and says values outside that range, in either direction, could prompt a review of stimulation, triggering or aspiration practice, because instability can mean more immature or more post-mature eggs 1. It also notes that nuclear maturity does not necessarily mean the egg is mature in every other respect 1.

My cycle was conventional IVF and there is no maturity number. Why?

Because nobody could see it. Maturity is assessed after the cumulus cells are removed from the egg, and that only happens in preparation for ICSI 1. In conventional IVF the eggs are inseminated inside their cumulus, so the Vienna consensus notes that oocyte maturity cannot be assessed at retrieval in routine IVF 1. Your report will show eggs collected and eggs fertilised instead.

Is a low maturity rate the laboratory's fault?

The consensus that set the range says explicitly that it is not a laboratory performance indicator, because its value is not influenced by laboratory practice 1. It is classified as a reference indicator reflecting what comes into the lab, and a value outside the range is meant to prompt a review of ovarian stimulation, triggering or follicle aspiration 1. The Maribor consensus uses it as a clinical indicator for the same reason 3.

How many eggs do you need before a low maturity rate means anything?

Enough that chance is not the explanation. A 2026 review in Human Reproduction makes this its central point: with too few eggs, statistical power is insufficient to tell real developmental arrest from normal biological variation 12. It proposes six collected eggs as the minimum before judging maturation, and diagnoses arrest at two or fewer mature eggs from six, in at least two treatment cycles 12.

Should we have genetic testing if most of my eggs are immature every time?

It is a reasonable question after a repeated pattern, and a specialist one. A 2026 review in Human Reproduction identified 39 genes linked to oocyte, zygote and embryo maturation arrest from 132 published papers 12. But a 2022 systematic review of genes in female reproductive failure classified 183 gene-disease pairs and found only 24 with definitive evidence and 36 with strong evidence 14. Ask what a test would change before agreeing to one.

Is oocyte maturation arrest the same as poor egg quality?

No. Maturation arrest describes eggs that stop at a specific point in meiosis and never reach metaphase II, and a 2026 review in Human Reproduction defines it by counts across at least two cycles 12. Egg quality is a broader and vaguer idea about what a mature egg can go on to do. An egg can be mature and still not produce a usable embryo, which is a different stage with different causes 1.

My clinic offered IVM because I have PCOS. Is that the same as rescuing my immature eggs?

No, they are different treatments. Planned IVM collects eggs from small follicles with little or no stimulation and matures them deliberately; the 2023 International PCOS Guideline says it could be considered as an alternative to a stimulated cycle, with no OHSS risk but a lower cumulative live birth rate 16. Rescue IVM salvages immature eggs from a stimulated cycle, and ESHRE does not recommend it for routine use 5.

Is rescue IVM safe for the baby?

It has not been established either way, and that is the reason it is not recommended routinely. ESHRE's 2023 add-ons group lists a lack of long-term safety data and calls the safety of rescue IVM questionable, because these eggs commonly have meiotic defects 5. The 2025 Istanbul consensus update says prenatal follow-up and follow-up of babies born after rescue IVM demands attention 2. Ask what follow-up your clinic offers.

Would a dual trigger have given me more mature eggs?

In an unselected cycle, probably not: a network meta-analysis of 12 randomised trials in 1,931 predicted healthy responders found no difference in the number of mature eggs between hCG, agonist, dual and double triggers 7. ESHRE's 2025 guideline advises against dual trigger for predicted normal and for low responders 4. One small randomised trial in 73 women selected for a previous immature rate above 50% did find a higher mature share with a dual trigger 8.

Sources

  1. ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine. The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators. Hum Reprod Open. 2017;2017(2):hox011. ESHRE / ALPHA / Human Reproduction Open
  2. Working Group on the update of the ESHRE/ALPHA Istanbul Consensus; Coticchio G, Ahlström A, Arroyo G, et al. The Istanbul consensus update: a revised ESHRE/ALPHA consensus on oocyte and embryo static and dynamic morphological assessment. Hum Reprod. 2025;40(6):1049-1091. ESHRE / ALPHA / Human Reproduction
  3. ESHRE Clinic PI Working Group; Vlaisavljevic V, Apter S, Capalbo A, D'Angelo A, Gianaroli L, et al. The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART. Hum Reprod Open. 2021;2021(3):hoab022. ESHRE / Human Reproduction Open
  4. ESHRE Guideline Group on Ovarian Stimulation; Ata B, Bosch E, Broer S, Griesinger G, Grynberg M, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025. Hum Reprod. 2026;41(4):498-514. ESHRE / Human Reproduction
  5. ESHRE Add-ons Working Group; Lundin K, Bentzen JG, Bozdag G, Ebner T, Harper J, et al. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38(11):2062-2104. ESHRE / Human Reproduction
  6. Human Fertilisation and Embryology Authority. Treatment add-ons with limited evidence: ratings and the October 2023 consensus statement. HFEA (UK regulator)
  7. Beebeejaun Y, Copeland T, Duffy JMN, Sarris I, Showell M, Wang R, Sunkara SK. Triggering oocyte maturation in in vitro fertilization treatment in healthy responders: a systematic review and network meta-analysis. Fertil Steril. 2025;123(5):812-826. Fertility and Sterility
  8. Yan MH, Sun ZG, Song JY. Dual trigger for final oocyte maturation in expected normal responders with a high immature oocyte rate: a randomized controlled trial. Front Med (Lausanne). 2023;10:1254982. Frontiers in Medicine
  9. Wang W, Zhang XH, Wang WH, Liu YL, Zhao LH, Xue SL, Yang KH. The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis. J Assist Reprod Genet. 2011;28(10):901-910. Journal of Assisted Reproduction and Genetics
  10. Gan R, Huang X, Zhao J, Zhang Q, Huang C, Li Y. Time interval between hCG administration and oocyte retrieval and ART outcomes: an updated systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):61. Reproductive Biology and Endocrinology
  11. Kummer NE, Feinn RS, Griffin DW, Nulsen JC, Benadiva CA, Engmann LL. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger. Hum Reprod. 2013;28(1):152-159. Human Reproduction
  12. Van Der Kelen A, Okutman Ö, Serdarogullari M, Dequeker BJH, Javey E, Capalbo A, et al. A comprehensive review for defining cut-off values of oocyte, zygote, and embryo maturation arrest (OZEMA) due to maternal-effect genes: towards the establishment of clinical criteria. Hum Reprod. 2026;41(7):1207-1219. Human Reproduction
  13. Feng R, Sang Q, Kuang Y, Sun X, Yan Z, Zhang S, et al. Mutations in TUBB8 and human oocyte meiotic arrest. N Engl J Med. 2016;374(3):223-232. New England Journal of Medicine
  14. Volozonoka L, Miskova A, Kornejeva L, Kempa I, Bargatina V, Gailite L. A systematic review and standardized clinical validity assessment of genes involved in female reproductive failure. Reproduction. 2022;163(6):351-363. Reproduction (Society for Reproduction and Fertility)
  15. ESHRE Working Group on Ultrasound in ART; D'Angelo A, Panayotidis C, Amso N, Marci R, Matorras R, et al. Recommendations for good practice in ultrasound: oocyte pick up. Hum Reprod Open. 2019;2019(4):hoz025. ESHRE / Human Reproduction Open
  16. Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-1679. ESHRE / ASRM / Monash University / Human Reproduction
  17. Donno V, García-Martínez S, Polyzos NP. Female BMI and body weight is not associated with oocyte yield and maturation in hCG, agonist or dual trigger cycles: a large observational study including 5000 cycles. J Clin Med. 2023;12(9):3249. Journal of Clinical Medicine

Tools for this step

WhatsApp us